13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 66 holding rows worth $136,970,409.
- Accession
- 0000935836-26-000090
- Filer
- CIK 1440771
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 66 entries on the cover page, a total value of $136,970,409 stated on the cover page (in dollars after the unit check, H1), rows summing to $136,970,409 with VALUE read as dollars as filed, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERASTEM INC | 92337C203 | COMMON STOCK | 2,732,079 | $21,091,650 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 740,000 | $13,497,600 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,631,588 | $10,850,060 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 569,088 | $5,099,028 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 2,348,147 | $4,813,701 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 709,505 | $3,739,091 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 85,000 | $3,593,800 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 100,000 | $3,588,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 389,916 | $3,173,916 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 460,359 | $3,171,874 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 115,000 | $3,057,850 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 353,669 | $2,938,989 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 339,902 | $2,780,398 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,352,032 | $2,775,398 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 100,000 | $2,671,000 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 50,000 | $2,622,000 | dollars as filed | call |
| SURROZEN INC | 86889P208 | COMMON STOCK | 113,631 | $2,568,061 | dollars as filed | |
| ALEXANDRIA REAL ESTATE EQ INC COM | 015271109 | REIT | 50,000 | $2,447,000 | dollars as filed | call |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 593,573 | $2,374,292 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 100,000 | $2,300,000 | dollars as filed | call |
| AYTU BIOPHARMA INC | 054754858 | COM | 813,704 | $2,115,630 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 50,000 | $2,114,000 | dollars as filed | call |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 200,000 | $1,864,000 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 220,011 | $1,852,493 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 19,742 | $1,719,726 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,237,802 | $1,609,143 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 100,000 | $1,577,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,150,759 | $1,438,449 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 228,894 | $1,403,120 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 893,100 | $1,348,581 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 662,666 | $1,338,585 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 701,000 | $1,296,850 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 78,189 | $1,128,267 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 486,400 | $1,074,944 | dollars as filed | |
| GERON CORP | 374163103 | COM | 805,800 | $1,063,656 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 200,000 | $1,054,000 | dollars as filed | call |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 87,682 | $1,039,909 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 156,179 | $982,366 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 687,500 | $976,250 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 710,071 | $852,085 | dollars as filed | |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 51,000,000 | $850,851 | dollars as filed | |
| SEMLER SCIENTIFIC INC | 81684M104 | COM | 50,000 | $764,500 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 469,018 | $726,978 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 627,668 | $715,542 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 204,770 | $634,787 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 463,700 | $625,995 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 45,000 | $595,350 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 86,359 | $489,656 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 305,400 | $467,262 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 256,106 | $417,453 | dollars as filed | |
| IN8BIO INC | 45674E208 | COM NEW | 164,893 | $385,850 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 50,000 | $385,000 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 171,100 | $374,709 | dollars as filed | |
| PASITHEA THERAPEUTICS CORP | 70261F202 | COM NEW | 275,062 | $354,830 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 230,050 | $280,661 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 20,000 | $276,000 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 27,232 | $275,043 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 131,144 | $258,354 | dollars as filed | |
| CNS PHARMACEUTICALS INC | 18978H508 | COM | 48,827 | $256,342 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 352,001 | $250,449 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 102,367 | $166,858 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 11,884 | $144,866 | dollars as filed | |
| EVAXION AS | 29970R303 | SPONSORED ADS | 20,000 | $95,400 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 126,270 | $80,838 | dollars as filed | |
| CURIS INC | 231269309 | COM | 59,349 | $58,583 | dollars as filed | |
| PROCESSA PHARMACEUTICALS INC | 74275C403 | COM SHS | 12,323 | $35,490 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000935836-26-000090 | this filing | 2026-02-13 | acceptance time not in the bulk data set |